retatrutide efficacy clinical trials safety Retatrutide, an experimental weight-loss drug, has not been approved by Retatrutide FDA Approval Status: July

Studies suggest subclinical hypothyroidism affects anywhere between 410% of the general population, with significantly higher rates in women and in people over 60 (NIH)

GLP-1 medications slow gastric emptying and may affect GLP-1 receptors in taste buds and brain reward centres, potentially altering how sweet or fatty foods taste and how pleasurable they feel

As we navigate the complexities of modern life, our bodies face increasing environmental stressors, leading many of us to consider supplementation for optimal health

XR spreads the dose over 10-12 hours, while IR delivers it faster and wears off in 4-6 hours

Symptoms such as severe stomach pain, vomiting, or unusual lumps in the neck should be reported to your healthcare provider immediately